rhodamine 123 has been researched along with Myelodysplastic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crouthamel, MH; Ho, RJ; Wu, D; Yang, Z | 1 |
| García-López, J; O'Connor, JE; Pétriz, J | 1 |
2 other study(ies) available for rhodamine 123 and Myelodysplastic Syndromes
| Article | Year |
|---|---|
A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells.
Topics: Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Doxorubicin; Drug Resistance; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Polymorphism, Single Nucleotide; Recombinant Proteins; Rhodamine 123; RNA, Messenger | 2006 |
Rhodamine 123 efflux in drug resistance assays.
Topics: Cell Line; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Dyes; Humans; Kinetics; Myelodysplastic Syndromes; Rhodamine 123; Rhodamines | 1996 |